MAR 2014

MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.

Issue link:

Contents of this Issue


Page 36 of 74

32 MARCH 2014 | Med Esthetics H is path to dermatology, however, was by way of urology, which he studied upon fi rst entering the Icahn School of Medicine at Mount Sinai in New York City. "In a sense, they both are fi elds where you see men, women and children of different ages and both have signifi cant procedures as part of the prac- tice," says Dr. Cohen. "But, ultimately, dermatology is a wonderful fi eld, where you have infectious disease and endocrinology in different age groups." A Passion for Research & Aesthetics At Mount Sinai, Dr. Cohen participated in medical research involving many cutting edge procedures. This experience fostered an interest in pursuing research as part of his career. He took that interest with him to his residency at one of the oldest dermatology programs in the country, Detroit's Henry Ford Hospital. While there, he worked with some of the biggest luminaries in the fi eld, including George Mikhail, MD, a pioneer in rhino- plasty, and Edward Krull, MD, who succeeded Clarence Livingood, MD, as the program's chairman. "Being able to work with [Dr. Krull] regularly throughout my resi- dency and seeing the surgical aspects of dermatology was incredible," says Dr. Cohen. He describes his training at Henry Ford as a "wonderful balance of medical, surgical and research-related dermatology. I saw fi rst hand that it was exciting to take care of patients in a clinical trial, to learn what procedures and medications are going to be approved, and to understand the whole process of investigation and how trials are designed." Dr. Cohen's interest in cosmetic dermatology was cemented during a combined Mohs and aesthetic dermatology fellowship in Vancouver, British Columbia, Canada, where he gained further training in skin cancer surgery, lasers and spent time each week learning Botox and fi llers with Drs. Alastair and Jean Carruthers. "Hav- ing had experience in learning the injections and being involved in two specifi c trials when I was in fellow- ship led me to really incorporate Botox and fi llers into my practice right from the get go," says Dr. Cohen. "I started my own clinical trials once I started practicing." The Move to Private Practice Following his training, Dr. Cohen felt that a private practice, driven by researched-backed data and encompassing medical, surgical and aesthetic dermatology would be a perfect fi t for his skills and pas- sions. And that is the practice he set out to build. He credits his wife Goldie, a pediatrician at Colorado Children's Hospital, with helping him design and create his current practices, which consist of 40% Mohs micrographic skin cancer surgery and 60% aesthetics. He works with three—and soon to be four—other doctors on a daily basis, and enjoys the opportunity to learn from his colleagues and share their respective research. "A lot of the research is aesthetic in terms of injectable, fi llers and botulinum toxin agents, as well as lasers," says Dr. Cohen. "It's really fun to see what's evolving and what technologies are going to be approved eventually. Some of it's medical and some surgical and, in many cases, it combines both worlds." His offi ce is currently performing studies on the use of lasers and injectable agents to minimize scars. "The principles in surgical and aesthetic dermatology are starting to show that they have a lot of synergy," SCIENCE AND SYNERGY Dr. Cohen's involvement in clinical studies allows him to off er treatments "that really work," he says. "I strive to always have the best technologies that are going to be a home run or at least a triple." S c i e n c e S y n e r g y M E D 3 1 4 . i n d d 3 2 Science Synergy MED314.indd 32 2 / 1 1 / 1 4 3 : 5 1 P M 2/11/14 3:51 PM

Articles in this issue

Archives of this issue

view archives of Medesthetics - MAR 2014